BioWorld Asia

Jan. 31, 2007

Faith In Bio Market Pays Off With Europe's Largest Fund

LONDON - Abingworth Management closed Europe's largest ever life sciences venture fund, Abingworth Bioventures V, capping the oversubscribed fund at £300 million (US$586.9 million). (BioWorld International) Read More

GPC Biotech Banks $44M Toward Satraplatin Launch

Sleep-Inducing Drug Strategy Promises Some Sweet Dreams

Avesthagen Closes €25M Round, Proclaims Leadership In India

No Abstract Read More

Cellectis Launches IPO, Seeking €16M to €21M

No Abstract Read More

Anglo-Australian Partnership Seeks New Cancer Therapies

New Ethics Warning Issued On Nanomedicine In Europe

Plant Biotech Expert Attacks 'Dysfunctional' Regulations

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

Depression concept with human, broken brain and heavy rain

CROI 2026 highlights depression and cognitive vulnerability in HIV

BioWorld

The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

University of Southern California reports new MAPT aggregation inhibitors

BioWorld Science

The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...